Skip to main content

Table 4 Main model analysis by sex, age, ethnicity, and deprivation: incremental costs, QALYsDW gained and ICERs for the CCC intervention compared to business-as-usual

From: Cancer care coordinators in stage III colon cancer: a cost-utility analysis

Population Incremental costs per patient (NZ$) QALYsDW gained per patient ICER (NZ$ per QALYDW)
Total (expected value analysis)a $2250 0.111 $20,200
By sex    
Males $2050 0.118 $17,400
Females $2520 0.121 $20,800
By age    
  < 65 years $1620 0.172 $9,400
  ≥ 65 years $2490 0.106 $23,600
By ethnicity by age    
Māori $3420 0.171 $20,000
  < 65 years $2810 0.223 $12,600
  ≥ 65 years $3730 0.147 $25,300
Non-Māori $2220 0.118 $18,800
  < 65 years $1510 0.167 $9,000
  ≥ 65 years $2420 0.104 $23,300
By deprivation    
Least deprived tertile $1880 0.125 $15,000
Most deprived tertile $2620 0.115 $22,800
Equity analysis: using non-Māori least deprived mortality and non-Māori average background morbidity
By ethnicity by age (percentage variation from equivalent above standard analysis)
Māori $3,780 (11 %) 0.251 (47 %) $15,100 (−25 %)
  < 65 years $3,250 (16 %) 0.317 (42 %) $10,300 (−18 %)
  ≥ 65 years $4,070 (9 %) 0.222 (51 %) $18,400 (−27 %)
Non-Māori $2,240 (1 %) 0.121 (3 %) $18,500 (−2 %)
  < 65 years $1,540 (2 %) 0.171 (2 %) $9,000 (0 %)
  ≥ 65 years $2,430 (0 %) 0.107 (3 %) $22,800 (−2 %)
  1. All models are expected value only; there is no parameter uncertainty
  2. Dollars are NZ$, for the year 2011. All costs and benefits discounted at 3 % per annum. All values rounded to three meaningful decimal places
  3. aNote that these results differ slightly from those in Table 3 due to not including uncertainty about parameters (due to long run time of models). Results in Table 3 are the preferred results, but the results in this table should be compared to this expected value analysis result which used the same modelling strategy